Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 101–200 of 1,002
Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy
Malik, R. A., Veves, A., Tesfaye, S., Smith, G., Cameron, N., Zochodne, D., Lauria, G., & Neuropathy, O. B. O. T. T. C. P. O. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1222 · Cited by 161
“Unmyelinated nerve fibre damage precedes myelinated nerve fibre damage in sural nerve biopsies and therefore may be used to detect early DSPN [7].”
BackgroundInfluentialSelf-citationThe clinical approach to small fibre neuropathy and painful channelopathy
Themistocleous, A. C., Ramirez, J. D., Serra, J., & Bennett, D. L. H. (2014) · Practical Neurology · doi:10.1136/practneurol-2013-000758 · Cited by 160
“…is suspected autonomic dysfunction on the basis of symptoms and examination, we recommend cardiovascular reflex testing, such as the Ewing protocol, 25 42 as an initial assessment of the autonomic nervous system, with subsequent referral for a more comprehensive assessment to include tests such as…”
MethodCorneal Confocal Microscopy Predicts 4-Year Incident Peripheral Neuropathy in Type 1 Diabetes
Pritchard, N., Edwards, K., Russell, A. W., Perkins, B. A., Malik, R. A., & Efron, N. (2015) · Diabetes Care · doi:10.2337/dc14-2114 · Cited by 160
Self-citationCazzato, D., & Lauria, G. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000472 · Cited by 160
Self-citationXu, F., Zhao, L.-H., Su, J.-B., Chen, T., Wang, X.-Q., Chen, J.-F., Wu, G., Jin, Y., & Wang, X.-H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-139 · Cited by 159
Yang, H., Sloan, G., Ye, Y., Wang, S., Duan, B., Tesfaye, S., & Gao, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00929 · Cited by 151
“Skin biopsy of the distal leg with quantification of intra-epidermal nerve fiber density (IENFD) is the gold standard technique to diagnose small fiber neuropathy (SFN) and it is also recommended for diagnosing DPN (16, 36).”
BackgroundMethodInfluentialSelf-citationAssociated conditions in small fiber neuropathy – a large cohort study and review of the literature
de Greef, B. T. A., Hoeijmakers, J. G. J., Gorissen-Brouwers, C. M. L., Geerts, M., Faber, C. G., & Merkies, I. S. J. (2017) · European Journal of Neurology · doi:10.1111/ene.13508 · Cited by 161
“The diagnosis of pure SFN is based on typical complaints, combined with abnormal intraepidermal nerve fiber density in skin biopsy and/ or abnormal temperature threshold testing levels, without signs of large nerve fiber involvement [1,3].”
BackgroundWilliams, B. M., Borroni, D., Liu, R., Zhao, Y., Zhang, J., Lim, J., Ma, B., Romano, V., Qi, H., Ferdousi, M., et al. (2020) · Diabetologia · doi:10.1007/s00125-019-05023-4 · Cited by 155
“There is also a need to compare the diagnostic ability of this DLAwith tests of small-fibre dysfunction (thermal thresholds/sudomotor/ autonomic) and IENF density in skin biopsy in DPN and other peripheral neuropathies.”
BackgroundInfluentialSelf-citationThe diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy
Smith, A. G., Lessard, M. K., Reyna, S. P., Doudova, M., & Singleton, J. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.02.013 · Cited by 157
Sartor, C. D., Hasue, R. H., Cacciari, L., Butugan, M. K., Watari, R., Pássaro, A. D. C., Giacomozzi, C., & Sacco, I. D. C. N. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-137 · Cited by 159
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Horváth, B., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.003 · Cited by 176
Gylfadottir, S. S., Christensen, D. H., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Itani, M., Khan, K. S., Kristensen, A. G., Nielsen, J. S., Sindrup, S. H., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001744 · Cited by 151
“There is no gold standard for identifying polyneuropathy for epidemiological research purposes, but the Michigan Neuropathy Screening Instrument questionnaire part (MNSIq)15 is a commonly used symptom-based screening tool for identifying DPN.2,8,43 We used the MNSIq and the validated cutoff of$4/13 abnormal responses…”
MethodInfluentialIncidence and prevalence of small-fiber neuropathy: A survey in the Netherlands
Peters, M. J. H., Bakkers, M., Merkies, I. S. J., Hoeijmakers, J. G. J., van Raak, E. P. M., & Faber, C. G. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a8236e · Cited by 153
“SFN is diagnosed based on typical SFN-related symptoms, normal nerve conduction tests, reduced intraepidermal nerve fiber density (IENFD), and/or abnormal temperature threshold tests.(1,2) To assess autonomic function, the Thermoregulatory Sweat Test, Sympathetic Skin Responses, and Quantitative Sudomotor Axon Reflex…”
BackgroundInfluentialHbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
Su, J., Zhao, L.-H., Zhang, X., Cai, H.-L., Huang, H., Xu, F., Chen, T., & Wang, X. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0693-0 · Cited by 174
“Confirmed DPN was diagnosed in patients displaying both the presence of neurological symptoms/signs and abnormalities in nerve conduction evaluations [12].”
BackgroundEarly Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
Burgess, J., Frank, B., Marshall, A. G., Khalil, R. S., Ponirakis, G., Petropoulos, I. N., Cuthbertson, D. J., Malik, R. A., & Alam, U. (2021) · Diagnostics · doi:10.3390/diagnostics11020165 · Cited by 179
“Skin biopsy of the distal leg and thigh with quantification of intra-epidermal nerve fibre density (IENFD) is considered to be the “gold standard” to diagnose small fibre neuropathy [6,177].”
BackgroundInfluentialSelf-citationActivated microglia in the spinal cord underlies diabetic neuropathic pain
Wang, D., Couture, R., & Hong, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.057 · Cited by 148
“toxicity associated with local metabolic and microvascular changes in both type I and type II diabetes mellitus (Tesfaye et al., 2010).”
Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy
Kasznicki, J., Kosmalski, M., Śliwińska, A., Mrowicka, M., Stańczyk, M. B., Majsterek, I., & Drzewoski, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1722-9 · Cited by 148
Novel pathogenic pathways in diabetic neuropathy
Zenker, J., Ziegler, D., & Chrast, R. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.008 · Cited by 159
Almurdhi, M. M., Reeves, N. D., Bowling, F. L., Boulton, A. J. M., Jeziorska, M., & Malik, R. A. (2016) · Diabetes Care · doi:10.2337/dc15-0995 · Cited by 173
Self-citationImmune system involvement in specific pain conditions
Totsch, S. K., & Sorge, R. E. (2017) · Molecular Pain · doi:10.1177/1744806917724559 · Cited by 144
“Diabetic neuropathy (DN) is a common nerve disorder affecting approximately half of those with diabetes.(160) It is a result of high blood glucose, typically due to diet and the development of Type 2 Diabetes Mellitus.”
BackgroundSmall fibers, large impact: Quality of life in small‐fiber neuropathy
Bakkers, M., Faber, C. G., Hoeijmakers, J. G. J., Lauria, G., & Merkies, I. S. J. (2013) · Muscle & Nerve · doi:10.1002/mus.23910 · Cited by 155
“Between January 2009 and August 2011, all patients with a definite clinical diagnosis of SFN were approached for participation in this study.(15) Eligibility was based on the following criteria: age 18 years and older; definite clinical diagnosis of SFN based on: (1) the presence of at least 2 of the following complai…”
MethodResultSelf-citationCefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 142
Small fiber neuropathy: Getting bigger!
Chan, A. C. Y., & Wilder-Smith, E. P. (2016) · Muscle & Nerve · doi:10.1002/mus.25082 · Cited by 159
“Graded diagnostic criteria for use in all forms of SFN, regardless of etiology, were proposed,(8) and included: (1) possible SFN, the presence of length-dependent symptoms, and/or clinical signs of small fiber damage; (2) probable SFN, the presence of length-dependent symptoms, clinical signs of small fiber damage, an…”
MethodEdwards, K. P., Pritchard, N., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2012) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2012.00740.x · Cited by 139
“It is argued that low to moderate correlations between different measures of neuropathy indicate that different tests for neuropathy are complementary(22) and that definitions for neuropathy should be multifactorial.(1) In addition, if, as speculated, corneal nerve morphology is a more sensitive marker of DPN than the…”
BackgroundSelf-citationRare NaV1.7 variants associated with painful diabetic peripheral neuropathy
Blesneac, I., Themistocleous, A. C., Fratter, C., Conrad, L. J., Ramirez, J. D., Cox, J. J., Tesfaye, S. H., SHILLO, P. R., Rice, A. S. C., Tucker, S. J., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001116 · Cited by 157
Self-citationLauria, G., Merkies, I. S. J., & Faber, C. G. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835804c5 · Cited by 141
Self-citationExosomes Derived From Schwann Cells Ameliorate Peripheral Neuropathy in Type 2 Diabetic Mice
Wang, L., Chopp, M., Szalad, A., Lu, X., Zhang, Y., Wang, X., Cepparulo, P., Lü, M., Li, C., & Zhang, Z. G. (2020) · Diabetes · doi:10.2337/db19-0432 · Cited by 140
Hotta, N., Kawamori, R., Fukuda, M., Shigeta, Y., & The Aldose Reductase Inhibitor–Diabetes Complications Trial Study Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03684.x · Cited by 139
Recent advances in the management of diabetic distal symmetrical polyneuropathy
Tesfaye, S. H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00083.x · Cited by 137
Self-citationDiagnosing Diabetic Neuropathy: Something Old, Something New
Petropoulos, I. N., Ponirakis, G., Khan, A., Almuhannadi, H., Gad, H., & Malik, R. A. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0056 · Cited by 148
“Bladder dysfunction has an estimated prevalence of 25% to 87% [29] and symptoms may include dysuria, nocturia, incomplete bladder emptying, and recurrent urinary tract infections [20].”
BackgroundMethodSelf-citationTannins and vascular complications of Diabetes: An update
Laddha, A. P., & Kulkarni, Y. A. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.026 · Cited by 148
The sensory role of the sole of the foot: Review and update on clinical perspectives
Viseux, F. (2020) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2019.12.003 · Cited by 152
Causes, prevention, and management of diabetes-related foot ulcers
Jeffcoate, W. J., Boyko, E. J., Game, F. L., Cowled, P., Senneville, E., & Fitridge, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00110-4 · Cited by 161
Vitamin D for the treatment of painful diabetic neuropathy
Basit, A., Basit, K. A., Fawwad, A., Shaheen, F., Fatima, N., Petropoulos, I. N., Alam, U., & Malik, R. A. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000148 · Cited by 138
Self-citationSmall‐fiber neuropathy: Expanding the clinical pain universe
Sopacua, M., Hoeijmakers, J. G. J., Merkies, I. S. J., Lauria, G., Waxman, S. G., & Faber, C. G. (2018) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12298 · Cited by 140
Self-citationCurrent concepts in the management of diabetic polyneuropathy
Ziegler, D., Παπάνας, Ν., Schnell, O., Nguyen, B. D., Nguyen, K. T., Kulkantrakorn, K., & Deerochanawong, C. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13401 · Cited by 171
Role of Neurologists and Diagnostic Tests on the Management of Distal Symmetric Polyneuropathy
Callaghan, B. C., Kerber, K. A., Lisabeth, L. D., Morgenstern, L. B., Longoria, R., Rodgers, A. F., Longwell, P. J., & Feldman, E. L. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1279 · Cited by 129
Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review
Williams, S. M., Eleftheriadou, A., Alam, U., Cuthbertson, D. J., & Wilding, J. P. H. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00693-0 · Cited by 128
Herder, C., Kannenberg, J. M., Huth, C., Carstensen‐Kirberg, M., Rathmann, W., Köenig, W., Heier, M., Püttgen, S., Thorand, B., Peters, A., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2259 · Cited by 137
Fasil, A., Biadgo, B., & Abebe, M. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s185614 · Cited by 130
“Diabetic polyneuropathy develops in the case of prolonged hyperglycemia, which is associated with metabolic imbalances, accumulation of advanced glycation end products, oxidative stress, and lipid alterations.(9) Diabetes management targets on maintenance of optimum glucose level and prevention and early diagnosis of…”
BackgroundThe Role of MicroRNAs in Diabetic Complications—Special Emphasis on Wound Healing
Moura, J., Børsheim, E., & Carvalho, E. (2014) · Genes · doi:10.3390/genes5040926 · Cited by 131
“Sensorimotor neuropathy may include pain, paraesthesia and sensory loss [108,109], while autonomic neuropathy may contribute to myocardial infarction, malignant arrhythmia and sudden death [110].”
BackgroundModeling nerve conduction criteria for diagnosis of diabetic polyneuropathy
Dyck, P. J., Carter, R. E., & Litchy, W. J. (2011) · Muscle & Nerve · doi:10.1002/mus.22074 · Cited by 132
Self-citationMassie, R., Mauermann, M. L., Staff, N. P., Amrami, K. K., Mandrekar, J. N., Dyck, P. J., Klein, C. J., & Dyck, P. J. (2012) · Brain · doi:10.1093/brain/aws244 · Cited by 124
“Diabetic polyneuropathy is classified into symmetrical lengthdependent and focal or multifocal varieties (Sinnreich et al., 2005; Tesfaye et al., 2010).”
BackgroundSelf-citationGold Standard for Diagnosis of DPN
Yu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.719356 · Cited by 126
Russell, J. W., & Zilliox, L. A. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000455884.29545.d2 · Cited by 158
Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis
Jiang, M., Yuan, Y., Gu, Z.-X., & Zhuang, S.-L. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306038 · Cited by 120
Diabetic peripheral neuropathy may not be as its name suggests
Tesfaye, S. H., Selvarajah, D., Gandhi, R. A., Greig, M., SHILLO, P. R., Fang, F., & Wilkinson, I. D. (2015) · Pain · doi:10.1097/j.pain.0000000000000465 · Cited by 122
Self-citationRole of Caveolin-1 in Diabetes and Its Complications
Haddad, D., Madhoun, A. S. A., Nizam, R., & Al‐Mulla, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9761539 · Cited by 146
“Painful diabetic peripheral neuropathy (DPN) is a common complication of T2DM affecting almost 50% of diabetic patients and is very challenging to treat [155].”
BackgroundExercise improves cardiac autonomic function in obesity and diabetes
Voulgari, C., Pagoni, S., Vinik, A. I., & Poirier, P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.005 · Cited by 139
Self-citationPrior, R. C., Helleputte, L. V., Benoy, V., & Bosch, L. V. D. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.009 · Cited by 130
Estación, M., Han, C., Choi, J., Hoeijmakers, J. G. J., Lauria, G., Drenth, J. P. H., Gerrits, M. M., Dib‐Hajj, S. D., Faber, C. G., Merkies, I. S. J., et al. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-92 · Cited by 120
“QST revealed abnormal warm and cold thresholds of the right foot.”
BackgroundInfluentialSelf-citationWang, W., Ji, Q., Ran, X., Li, C., Kuang, H., Yu, X., Fang, H., Yang, J., Liu, J., Xue, Y., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3702 · Cited by 135
“The use of scores, such as TCSS, 8 might help standardise DPN screening, but further studies are still necessary.”
MethodDiagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests
Lefaucheur, J. P., Wahab, A., Planté‐Bordeneuve, V., Sène, D., Ménard‐Lefaucheur, I., Rouie, D., Tebbal, D., Salhi, H., Créange, A., Zouari, H. G., et al. (2015) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2015.09.012 · Cited by 115
Central Obesity is Associated With Neuropathy in the Severely Obese
Callaghan, B. C., Reynolds, E., Banerjee, M., Chant, E., Villegas-Umana, E., & Feldman, E. L. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.025 · Cited by 115
“Polyneuropathy Definition (primary outcome) Our primary outcome measure was the Toronto consensus definition of probable polyneuropathy, which requires 2 or more of the following: neuropathy symptoms, abnormal sensory examination, and abnormal reflexes as determined by one of 4 neuromuscular specialists.[19]”
BackgroundThe Look AHEAD Research Group (2017) · Diabetologia · doi:10.1007/s00125-017-4253-z · Cited by 121
“Diabetic neuropathies are a heterogeneous group of disorders of varying aetiology and clinical presentation [1].”
Diabetic Sensory and Motor Neuropathy
Vinik, A. I. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503948 · Cited by 113
Self-citationSmall fiber neuropathy: diagnosis, causes, and treatment
Sène, D. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.11.002 · Cited by 113
Selvarajah, D., Wilkinson, I. D., Fang, F., Sankar, A., Davies, J., Boland, E. G., Harding, J., Rao, G., Gandhi, R. A., Tracey, I., et al. (2019) · Diabetes · doi:10.2337/db18-0509 · Cited by 113
Self-citationChowdhury, M., Nevitt, S. J., Eleftheriadou, A., Kanagala, P., Esa, H., Cuthbertson, D. J., Tahrani, A. A., & Alam, U. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002480 · Cited by 125
Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Herder, C., Stöckl, D., Meisinger, C., & Ziegler, D. (2013) · Diabetes Care · doi:10.2337/dc12-0744 · Cited by 106
Novodvorsky, P., Bernjak, A., Chow, E., Iqbal, A., Sellors, L., Williams, S., Fawdry, R. A., Parekh, B., Jacques, R. M., Marques, J. L. B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2177 · Cited by 111
“Cardiovascular autonomic tests were performed at the onset of the monitoring period in accordance with a recently published consensus statement (22).”
BackgroundMethodInfluentialZiegler, D., & Fonseca, V. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.08.008 · Cited by 120
“Diabetic polyneuropathy is among the most common long-term complications of DM, affecting up to 50% of diabetic patients (Tesfaye et al., 2010).”
BackgroundMorrison, S., Colberg, S. R., Parson, H. K., & Vinik, A. I. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.007 · Cited by 113
Self-citationChristensen, D. H., Knudsen, S. T., Gylfadottir, S. S., Christensen, L. B., Nielsen, J. S., Beck‐Nielsen, H., Sørensen, H. T., Andersen, H., Callaghan, B. C., Feldman, E. L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2277 · Cited by 119
Gregorio, C. D., Contador, D., Díaz, D. A., Cárcamo, C., Santapau, D., Lobos‐González, L., Acosta, C. G., Campero, M., Carpio, D., Gabriele, C., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01680-0 · Cited by 114
Diabetic neuropathy and foot complications
Boulton, A. J. M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00008-4 · Cited by 108
“It is estimated that up to 50% of patients with DPN will experience some symptoms whereas a similar number may be asymptomatic or if prompted, admit to negative symptoms (Tesfaye et al., 2010).”
BackgroundSelf-citationFerdousi, M., Kalteniece, A., Azmi, S., Petropoulos, I. N., Ponirakis, G., Alam, U., Asghar, O., Marshall, A. G., Fullwood, C., Jeziorska, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1482 · Cited by 110
Self-citationSensory-Motor Mechanisms Increasing Falls Risk in Diabetic Peripheral Neuropathy
Reeves, N. D., Orlando, G., & Brown, S. J. (2021) · Medicina · doi:10.3390/medicina57050457 · Cited by 135
“The Toronto consensus statement recommends as criteria for the diagnosis of DPN the combination of abnormalities in nerve conduction studies and the presence of one or more signs or symptoms [21].”
MethodGin, H., Baudoin, R., Raffaitin, C., Rigalleau, V., & González, C. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.05.003 · Cited by 107
Type 1 diabetes and cardiovascular disease
Schnell, O., Cappuccio, F. P., Genovese, S., Standl, E., Valensi, P. E., & Ceriello, A. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-156 · Cited by 126
“CV sympathetic function is assessed by measuring the blood pressure response to standing [92].”
MethodSelf-citationSmall fiber neuropathy in Fabry disease
Biegstraaten, M., Hollak, C. E. M., Bakkers, M., Faber, C. G., Aerts, J. M. F. G., & van Schaik, I. N. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.010 · Cited by 106
Prevalence of peripheral neuropathy in pre-diabetes: a systematic review
Kirthi, V., Perumbalath, A., Brown, E. E., Nevitt, S. J., Petropoulos, I. N., Burgess, J., Roylance, R., Cuthbertson, D. J., Jackson, T. L., Malik, R. A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002040 · Cited by 121
“7 However, abnormalities in NCS which assess large myelinated nerve fibers that subserve touch, proprioception, vibration and motor function are later manifestations of DPN. 8 By contrast, small nerve fiber deficits affecting unmyelinated or thinly myelinated C and A δ nerve fibers involved in…”
Self-citationStavniichuk, R., Drel, V. R., Shevalye, H., Maksimchyk, Y., Kuchmerovska, T. M., Nadler, J. L., & Obrosova, I. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.002 · Cited by 106
“Unfortunately, all monotherapies for DPN studied so far, including AR and protein kinase C inhibitors, acetyl carnitine, nerve growth factor, and the antioxidant α-lipoic acid, showed modest efficacy in clinical trials, or have been abandoned due to adverse side effects (Tesfaye et al, 2010).”
Entrapment neuropathies in diabetes mellitus
Rota, E., & Morelli, N. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.342 · Cited by 105
New technologies for the assessment of neuropathies
Gasparotti, R., Padua, L., Briani, C., & Lauria, G. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.31 · Cited by 111
Self-citationDeclining Skeletal Muscle Function in Diabetic Peripheral Neuropathy
Parasoglou, P., Rao, S., & Slade, J. M. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.05.001 · Cited by 117
Quick and Simple Evaluation of Sudomotor Function for Screening of Diabetic Neuropathy
Yajnik, C. S., Kantikar, V., Pande, A. J., & Deslypere, J. P. (2012) · ISRN Endocrinology · doi:10.5402/2012/103714 · Cited by 106
Painful and non‐painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues
Gylfadottir, S. S., Weeracharoenkul, D., Andersen, S. T., Niruthisard, S., Suwanwalaikorn, S., & Jensen, T. S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13105 · Cited by 121
Central nervous system involvement in diabetic neuropathy
Selvarajah, D., Wilkinson, I. D., Davies, J., Gandhi, R., & Tesfaye, S. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0205-z · Cited by 102
Self-citationDiabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
The International Association of Diabetes in Pregnancy Study Group (IADPSG) Working Group on Outcome Definitions, Feig, D. S., Corcoy, R., Jensen, D. M., Kautzky‐Willer, A., Nolan, C. J., Oats, J. J. N., Sacks, D. A., Caimari, F., & McIntyre, H. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2640 · Cited by 100
Kalteniece, A., Ferdousi, M., Petropoulos, I. N., Azmi, S., Adam, S., Fadavi, H., Marshall, A. G., Boulton, A. J. M., Efron, N., Faber, C. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21643-z · Cited by 102
Self-citationVitamin D and diabetes mellitus: Causal or casual association?
Grammatiki, M., Rapti, E., Karras, S. Ν., Ajjan, R., & Kotsa, K. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9403-y · Cited by 117
Gad, H., Petropoulos, I. N., Khan, A., Ponirakis, G., MacDonald, R. S., Alam, U., & Malik, R. A. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13643 · Cited by 101
Self-citationAndersen, S. T., Witte, D. R., Fleischer, J., Andersen, H., Lauritzen, T., Jørgensen, M. E., Jensen, T. S., Pop-Busui, R., & Charles, M. (2018) · Diabetes Care · doi:10.2337/dc18-1411 · Cited by 99
The Inferior Whorl For Detecting Diabetic Peripheral Neuropathy Using Corneal Confocal Microscopy
Petropoulos, I. N., Ferdousi, M., Marshall, A. G., Alam, U., Ponirakis, G., Azmi, S., Fadavi, H., Efron, N., Tavakoli, M., & Malik, R. A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15919 · Cited by 107
Self-citationWang, S., Xu, H., Zou, L., Xie, J., Wu, H., Wu, B., Yi, Z., Lv, Q., Zhang, X., Ying, M., et al. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9488-x · Cited by 107
“DNP is a result of glucose toxicity associated with local metabolic changes in DM [5, 8].”
BackgroundEngineering digital biomarkers of interstitial glucose from noninvasive smartwatches
Bent, B., Cho, P. J., Henriquez, M., Wittmann, A., Thacker, C., Feinglos, M. N., Crowley, M. J., & Dunn, J. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00465-w · Cited by 121
Dehghani, C., Pritchard, N., Edwards, K. P., Russell, A. W., Malik, R. A., & Efron, N. (2014) · Cornea · doi:10.1097/ico.0000000000000152 · Cited by 100
Self-citationCapece, U., Moffa, S., Improta, I., Giuseppe, G. D., Nista, E. C., CEFALO, C. M. A., Cinti, F., Pontecorvi, A., Gasbarrini, A., Giaccari, A., et al. (2022) · Nutrients · doi:10.3390/nu15010018 · Cited by 109
“Electroneurography is the main diagnostic tool, confirming the presence of DPN in symptomatic patients and highlighting alterations in peripheral nerve conduction [105].”
BackgroundJaiswal, M., Martin, C. L., Brown, M. B., Callaghan, B., Albers, J. W., Feldman, E. L., & Pop-Busui, R. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.013 · Cited by 96
“Diabetic peripheral neuropathy (DPN) affects nearly two-thirds of patients with diabetes and is a major cause of poor quality of life (1) Despite the proven efficacy of intensive glucose control in delaying or preventing DPN and cardiovascular autonomic neuropathy (CAN) in patients with type 1 diabetes (T1D)(2-4), equ…”
BackgroundWon, J. C., Kwon, H., Kim, C. H., Lee, J. H., Park, T. S., Ko, K. S., & Cha, B. Y. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03697.x · Cited by 97
Painful neuropathies: the emerging role of sodium channelopathies
Brouwer, B. A., Merkies, I. S. J., Gerrits, M. M., Waxman, S. G., Hoeijmakers, J. G. J., & Faber, C. G. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12071 · Cited by 98
“Multiple causes for SFN have been described, such as diabetes mellitus, hyperlipidemia, amyloidosis, Fabry syndrome, celiac disease, sarcoidosis and other systemic illnesses, and human immunodeficiency virus (HIV) infection (McManis et al., 1994; Lacomis et al., 1997; Scott et al., 1999; Smith et al., 2001; Hoitsma et…”
BackgroundLee, J. A., Halpern, E. M., Lovblom, L. E., Yeung, E. F. Y., Bril, V., & Perkins, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086515 · Cited by 98
“[11,12] Measurement of these electrophysiological parameters is time-consuming and expensive, and access to care is hindered by the limited number of clinics available to perform standard nerve conduction assessments in the face of the increasing prevalence of diabetes.”
BackgroundMethodInfluentialThe Biology of Bone and Ligament Healing
Cottrell, J. A., Turner, J. C., Arinzeh, T. L., & O’Connor, J. P. (2016) · Foot and Ankle Clinics · doi:10.1016/j.fcl.2016.07.017 · Cited by 94
Brock, C., Hansen, C. S., Karmisholt, J., Møller, H. J., Juhl, A. H., Farmer, A. D., Drewes, A. M., Riahi, S., Lervang, H. H., Jakobsen, P. E., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14063 · Cited by 96
“All patients underwent nerve conduction tests to diagnose DSPN according to the Toronto criteria not more than 4 weeks prior to study entering.(14) Prior to entering the study, prescribed medication e.”
MethodCardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
Williams, S., Raheim, S. A., Khan, M. I., Rubab, U., Kanagala, P., Zhao, S. S., Worthington, A., Brown, E. E., & Alam, U. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.002 · Cited by 112
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
Maalmi, H., Strom, A., Petrera, A., Hauck, S. M., Straßburger, K., Kuß, O., Zaharia, O., Bönhof, G. J., Rathmann, W., Trenkamp, S., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05846-8 · Cited by 96
“All nerve stimulations were performed using surface electrodes (Nicolet VikingQuest; Natus Medical, San Carlos, CA, USA) after warming up feet and lower legs to ensure that skin temperature was 33 – 34°C. QST was evaluated by thermal detection thresholds (TDTs) to warm and cold stimuli at the thenar eminence and dorsu…”
InfluentialSivaskandarajah, G. A., Halpern, E. M., Lovblom, L. E., Weisman, A., Orlov, S., Bril, V., & Perkins, B. A. (2013) · Diabetes Care · doi:10.2337/dc12-2075 · Cited by 94
Greco, C., Gennaro, F. D., D’Amato, C., Morganti, R., Corradini, D., Sun, A., Longo, S., Lauro, D., Pierangeli, G., Cortelli, P., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13310 · Cited by 95
Self-citationTRPV1: Receptor structure, activation, modulation and role in neuro-immune interactions and pain
Maximiano, T. K. E., Carneiro, J. A., Fattori, V., & Verri, W. A., Jr. (2024) · Cell Calcium · doi:10.1016/j.ceca.2024.102870 · Cited by 103
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.